Thomas M. Schmitt - Concepedia

Author

Thomas M. Schmitt

Also Known As

Schmitt, Thomas, Schmitt, Thomas M, T M Schmitt, T Schmitt, T. M. Schmitt, T. Schmitt, Thomas M Schmitt, Thomas M. Schmitt, Thomas Schmitt, Thomas M. Schmitt

108

Publications

5.6K

Citations

H-Index

Concepts

All Affiliations

University of Washington Fred Hutch Cancer Center University of Toronto Sunnybrook Health Science Centre Health Sciences Centre

About

Thomas M. Schmitt is an author at University of Washington specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	2.7K
2	Cell Biology	10	10	2.6K
3	Cellular Therapies	3	3	1.4K
4	Health Sciences	2	2	378
5	Cellular Physiology	1	1	413

Thomas M. Schmitt

Publications

4.9K

Citations

H-Index

Page 1

	Year	Citations
Induction of T Cell Development from Hematopoietic Progenitor Cells by Delta-like-1 In Vitro Thomas M. Schmitt, Juan Carlos Zúñiga‐Pflücker Immunity Cell TherapyT Cell DevelopmentDevelopmental BiologyLymphocyte DevelopmentT-regulatory Cell	2002	1.1K
Heterogeneity among DN1 Prothymocytes Reveals Multiple Progenitors with Different Capacities to Generate T Cell and Non-T Cell Lineages Helen E. Porritt, Lynn L. Rumfelt, Sahba Tabrizifard, Immunity Cell LineageLineage PlasticityDevelopmental BiologyNon-t Cell LineagesDifferent Capacities	2004	413
Induction of T cell development and establishment of T cell competence from embryonic stem cells differentiated in vitro Thomas M. Schmitt, Renée F. de Pooter, Matthew A. Gronski, Nature Immunology Regenerative MedicineEmbryonic Stem CellT Cell DevelopmentDevelopmental BiologyCell Specialization	2004	360
Maintenance of T Cell Specification and Differentiation Requires Recurrent Notch Receptor–Ligand Interactions Thomas M. Schmitt, Maria Ciofani, Howard T. Petrie, The Journal of Experimental Medicine	2004	318
T cell receptor gene therapy targeting WT1 prevents acute myeloid leukemia relapse post-transplant Aude G. Chapuis, Daniel Egan, Merav Bar, Nature Medicine Cell TherapyTransplantationT-regulatory CellImmunologyAutoimmunity	2019	310
Transferred WT1-Reactive CD8 <sup>+</sup> T Cells Can Mediate Antileukemic Activity and Persist in Post-Transplant Patients Aude G. Chapuis, Gunnar B. Ragnarsson, Hieu Nguyen, Science Translational Medicine	2013	306
The B-cell tumor–associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor Michael Hudecek, Thomas M. Schmitt, Sivasubramanian Baskar, Blood	2010	264
Obligatory Role for Cooperative Signaling by Pre-TCR and Notch during Thymocyte Differentiation Maria Ciofani, Thomas M. Schmitt, Amelia Ciofani, The Journal of Immunology	2004	249
IL-34 and CSF-1 display an equivalent macrophage differentiation ability but a different polarization potential Sonia Boulakirba, Anja Pfeifer, Rana Mhaidly, Scientific Reports	2018	198
T Cells Engineered against a Native Antigen Can Surmount Immunologic and Physical Barriers to Treat Pancreatic Ductal Adenocarcinoma Ingunn M. Stromnes, Thomas M. Schmitt, Ayaka Hulbert, Cancer Cell Physical BarriersTumor ImmunologyPancreatic CancerCancer ImmunosurveillanceT-regulatory Cell	2015	194

Page 1